How generic Requip may lead to the extinction of restless legs syndrome:
Last week, the drug agency approved the first generic versions of ropinirole tablets for four manufacturers. The move is likely to send Requip sales and advertising plummeting, industry experts predicted.At least one sleep disorder specialist expects the focus on restless legs syndrome to fade as rapidly as the Requip television commercials “” which have already been pulled from the airwaves.
